Activation of necroptosis in human and experimental cholestasis

Cell Death and Disease

Volumn 7, Issue 9, 2016, Pages

  Afonso, Marta B ^a   Rodrigues, Pedro M ^a   Simão, André L ^a   Ofengeim, DImitry ^b   Carvalho, Tânia ^c   Amaral, Joana D ^a   Gaspar, Maria M ^a   Cortez Pinto, Helena ^d,e   Castro, Rui E ^a   Yuan, Junying ^b   Rodrigues, Cecília M P ^a  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^b HARVARD MEDICAL SCHOOL   (United States)

^c INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^d HOSPITAL DE SANTA MARIA   (Portugal)

^e INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CELL PROTEIN; HEME OXYGENASE 1; IRON; MIXED LINEAGE KINASE; RIP1 PROTEIN; RIP3 PROTEIN; THIOFLAVINE; UNCLASSIFIED DRUG; BILE ACID; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RIPK3 PROTEIN, MOUSE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ASSAY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT LIGATION; BILIRUBIN BLOOD LEVEL; CELL ACTIVATION; CHOLANGITIS; CHOLESTASIS; COMMON BILE DUCT; CONTROLLED STUDY; CYTOTOXICITY ASSAY; EXPERIMENTAL CHOLESTASIS; FEMALE; FIBROSIS; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPLASIA; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LIPID PEROXIDATION; LIVER BIOPSY; LIVER CELL; LIVER INJURY; LIVER TISSUE; MOUSE; NECROPTOSIS; NECROSIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION; WILD TYPE; ACUTE DISEASE; ANIMAL; APOPTOSIS; BILE DUCT; C57BL MOUSE; CHRONIC DISEASE; COMPLICATION; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; ENZYME ACTIVATION; LIGATION; LIVER; LIVER CIRRHOSIS; METABOLISM; PATHOLOGY;

ACUTE DISEASE; ANIMALS; APOPTOSIS; BILE ACIDS AND SALTS; BILE DUCTS; CHOLESTASIS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; FEMALE; HEME OXYGENASE-1; HEPATOCYTES; HUMANS; INFLAMMATION; IRON; LIGATION; LIVER; LIVER CIRRHOSIS; MICE, INBRED C57BL; NECROSIS; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES;

EID: 85019011199     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2016.280     Document Type: Article

References (50)

1. Castro RE, Rodrigues CMP. Cell death and microRNAs in cholestatic liver diseases: update on potential therapeutic applications. Curr Drug Targets 2016 (in press).
2. Lazaridis KN, LaRusso NF. The cholangiopathies. Mayo Clin Proc 2015; 90: 791-800.
3. Xia X, Demorrow S, Francis H, Glaser S, Alpini G, Marzioni M et al. Cholangiocyte injury and ductopenic syndromes. Semin Liver Dis 2007; 27: 401-412.
4. V Vanden Berghe T, Linkermann A, Jouan-Lanhouet S, Walczak H, Vandenabeele P. Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat Rev Mol Cell Biol 2014; 15: 135-147.
5. He S, Wang L, Miao L, Wang T, Du F, Zhao L et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 2009; 137: 1100-1111.
6. Li J, McQuade T, Siemer AB, Napetschnig J, Moriwaki K, Hsiao YS et al. The RIP1/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis. Cell 2012; 150: 339-350.
7. Wang H, Sun L, Su L, Rizo J, Liu L, Wang LF et al. Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol Cell 2014; 54: 133-146.
8. Cai Z, Jitkaew S, Zhao J, Chiang HC, Choksi S, Liu J et al. Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis. Nat Cell Biol 2014; 16: 55-65.
9. Roychowdhury S, McMullen MR, Pisano SG, Liu X, Nagy LE. Absence of receptor interacting protein kinase 3 prevents ethanol-induced liver injury. Hepatology 2013; 57: 1773-1783.
10. Gautheron J, Vucur M, Reisinger F, Vargas Cardenas D, Roderburg C, Koppe C et al. A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis. EMBO Mol Med 2014; 6: 1062-1074.
11. Afonso MB, Rodrigues PM, Carvalho T, Caridade M, Borralho P, Cortez-Pinto H et al. Necroptosis is a key pathogenic event in human and experimental murine models of nonalcoholic steatohepatitis. Clin Sci (Lond) 2015; 129: 721-739.
12. Yang X, Chao X, Wang ZT, Ding WX. The end of RIPK1-RIPK3-MLKL-mediated necroptosis in acetaminophen-induced hepatotoxicity? Hepatology 2015; 64: 311-312.
13. Ramachandran A, McGill MR, Xie Y, Ni HM, Ding WX, Jaeschke H. Receptor interacting protein kinase 3 is a critical early mediator of acetaminophen-induced hepatocyte necrosis in mice. Hepatology 2013; 58: 2099-2108.
14. Deutsch M, Graffeo CS, Rokosh R, Pansari M, Ochi A, Levie EM et al. Divergent effects of RIP1 or RIP3 blockade in murine models of acute liver injury. Cell Death Dis 2015; 6: e1759.
15. Bjornsson E, Olsson R. Outcome and prognostic markers in severe drug-induced liver disease. Hepatology 2005; 42: 481-489.
16. Liedtke C, Bangen JM, Freimuth J, Beraza N, Lambertz D, Cubero FJ et al. Loss of caspase-8 protects mice against inflammation-related hepatocarcinogenesis but induces non-apoptotic liver injury. Gastroenterology 2011; 141: 2176-2187.
17. Vucur M, Reisinger F, Gautheron J, Janssen J, Roderburg C, Cardenas DV et al. RIP3 inhibits inflammatory hepatocarcinogenesis but promotes cholestasis by controlling caspase-8- and JNK-dependent compensatory cell proliferation. Cell Rep 2013; 4: 776-790.
18. Newton K, Dugger DL, Wickliffe KE, Kapoor N, de Almagro MC, Vucic D et al. Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis. Science 2014; 343: 1357-1360.
19. Dondelinger Y, Aguileta MA, Goossens V, Dubuisson C, Grootjans S, Dejardin E et al. RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition. Cell Death Differ 2013; 20: 1381-1392.
20. Vince JE, Wong WW, Gentle I, Lawlor KE, Allam R, O'Reilly L et al. Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation. Immunity 2012; 36: 215-227.
21. Ofengeim D, Ito Y, Najafov A, Zhang Y, Shan B, DeWitt JP et al. Activation of necroptosis in multiple sclerosis. Cell Rep 2015; 10: 1836-1849.
22. Wu XN, Yang ZH, Wang XK, Zhang Y, Wan H, Song Y et al. Distinct roles of RIP1-RIP3 hetero- and RIP3-RIP3 homo-interaction in mediating necroptosis. Cell Death Differ 2014; 21: 1709-1720.
23. Luedde T, Kaplowitz N, Schwabe RF. Cell death and cell death responses in liver disease: mechanisms and clinical relevance. Gastroenterology 2014; 147: 765-783 e764.
24. Conde de la Rosa L, Vrenken TE, Hannivoort RA, Buist-Homan M, Havinga R, Slebos DJ et al. Carbon monoxide blocks oxidative stress-induced hepatocyte apoptosis via inhibition of the p54 JNK isoform. Free Radic Biol Med 2008; 44: 1323-1333.
25. Wang QM, Duan ZJ, Du JL, Guo SB, Sun XY, Liu Z. Heme oxygenase/carbon monoxide pathway inhibition plays a role in ameliorating fibrosis following splenectomy. Int J Mol Med 2013; 31: 1186-1194.
26. Wei CL, Lee KH, Khoo HE, Hon WM. Expression of haem oxygenase in cirrhotic rat liver. J Pathol 2003; 199: 324-334.
27. Datta PK, Koukouritaki SB, Hopp KA, Lianos EA. Heme oxygenase-1 induction attenuates inducible nitric oxide synthase expression and proteinuria in glomerulonephritis. J Am Soc Nephrol 1999; 10: 2540-2550.
28. Huang TY, Tsai PS, Huang CJ. HO-1 overexpression attenuates endotoxin effects on CAT-2 sozymes expression. J Surg Res 2008; 148: 172-180.
29. Tiao MM, Lin TK, Kuo FY, Huang CC, Du YY, Chen CL et al. Early stage of biliary atresia is associated with significant changes in 8-hydroxydeoxyguanosine and mitochondrial copy number. J Pediatr Gastroenterol Nutr 2007; 45: 329-334.
30. Silke J, Rickard JA, Gerlic M. The diverse role of RIP kinases in necroptosis and inflammation. Nat Immunol 2015; 16: 689-697.
31. He S, Liang Y, Shao F, Wang X. Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway. Proc Natl Acad Sci USA 2011; 108: 20054-20059.
32. Gozzelino R, Jeney V, Soares MP. Mechanisms of cell protection by heme oxygenase-1. Annu Rev Pharmacol Toxicol 2010; 50: 323-354.
33. Froh M, Conzelmann L, Walbrun P, Netter S,Wiest R, Wheeler MD et al. Heme oxygenase-1 overexpression increases liver injury after bile duct ligation in rats. World J Gastroenterol 2007; 13: 3478-3486.
34. Guo SB, Li Q, Duan ZJ, Wang QM, Zhou Q, Sun XY. Octreotide attenuates liver fibrosis by inhibiting hepatic heme oxygenase-1 expression. Mol Med Rep 2015; 11: 83-90.
35. Amersi F, Buelow R, Kato H, Ke B, Coito AJ, Shen XD et al. Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J Clin Invest 1999; 104: 1631-1639.
36. Bakhautdin B, Das D, Mandal P, Roychowdhury S, Danner J, Bush K et al. Protective role of HO-1 and carbon monoxide in ethanol-induced hepatocyte cell death and liver injury in mice. J Hepatol 2014; 61: 1029-1037.
37. Wang QM, Du JL, Duan ZJ, Guo SB, Sun XY, Liu Z. Inhibiting heme oxygenase-1 attenuates rat liver fibrosis by removing iron accumulation. World J Gastroenterol 2013; 19: 2921-2934.
38. Georgiev P, Jochum W, Heinrich S, Jang JH, Nocito A, Dahm F et al. Characterization of time-related changes after experimental bile duct ligation. Br J Surg 2008; 95: 646-656.
39. Muchova L, Vanova K, Suk J, Micuda S, Dolezelova E, Fuksa L et al. Protective effect of heme oxygenase induction in ethinylestradiol-induced cholestasis. J Cell Mol Med 2015; 19: 924-933.
40. Kahraman A, Barreyro FJ, Bronk SF, Werneburg NW, Mott JL, Akazawa Y et al. TRAIL mediates liver injury by the innate immune system in the bile duct-ligated mouse. Hepatology 2008; 47: 1317-1330.
41. Canbay A, Feldstein A, Baskin-Bey E, Bronk SF, Gores GJ. The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse. J Pharmacol Exp Ther 2004; 308: 1191-1196.
42. Olynyk JK St, Pierre TG, Britton RS, Brunt EM, Bacon BR. Duration of hepatic iron exposure increases the risk of significant fibrosis in hereditary hemochromatosis: a new role for magnetic resonance imaging. Am J Gastroenterol 2005; 100: 837-841.
43. Ramm GA, Ruddell RG. Hepatotoxicity of iron overload: mechanisms of iron-induced hepatic fibrogenesis. Semin Liver Dis 2005; 25: 433-449.
44. Wang F, Duan ZJ, Sun YJ. Influence of heme oxygenase-1 expression on immune liver fibrosis induced by cobalt protoporphyrin in rats. World J Gastroenterol 2009; 15: 3009-3014.
45. Barikbin R, Neureiter D, Wirth J, Erhardt A, Schwinge D, Kluwe J et al. Induction of heme oxygenase 1 prevents progression of liver fibrosis in Mdr2 knockout mice. Hepatology 2012; 55: 553-562.
46. Newton K, Sun X, Dixit VM. Kinase RIP3 is dispensable for normal NF-kappa Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4. Mol Cell Biol 2004; 24: 1464-1469.
47. Mariash CN, Seelig S, Schwartz HL, Oppenheimer JH. Rapid synergistic interaction between thyroid hormone and carbohydrate on mRNAS14 induction. J Biol Chem 1986; 261: 9583-9586.
48. Castro RE, Ferreira DM, Zhang X, Borralho PM, Sarver AL, Zeng Y et al. Identification of microRNAs during rat liver regeneration after partial hepatectomy and modulation by ursodeoxycholic acid. Am J Physiol Gastrointest Liver Physiol 2010; 299: G887-G897.
49. Gozzelino R, Andrade BB, Larsen R, Luz NF, Vanoaica L, Seixas E et al. Metabolic adaptation to tissue iron overload confers tolerance to malaria. Cell Host Microbe 2012; 12: 693-704.
50. Rodrigues PM, Afonso MB, Simão AS, Borralho PM, Rodrigues CMP, Castro RE. Inhibition of NF-kappaB by deoxycholic acid induces miR-21/PDCD4-dependent hepatocelular apoptosis. Sci Rep 2015; 5: 17528.